Switzerland· 17885014
Mysoline, Tabletten
A primidone product containing primidonum, registered in Switzerland by Curatis AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Primidone is registered in 17 of 19 countries.
Countries holding a registration under ATC N03AA03 (primidone), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Primidone · ATC N03AA03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of primidone costs, country by country.
Normalised to the WHO defined daily dose (1.25 g), the median price runs from $0.86 in Italy to $2.61 in Switzerland — a ×3.0 gap.
- Switzerland: $2.61 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Primidone · price per daily dose (1.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.61
- FR France$0.88
- IT Italy$0.86
The record
At a glance
Swissmedic (Switzerland)- Active substance
- primidonum
- Manufacturer
- Curatis AG
- Country
- Switzerland (CH)
- ATC code
- N03AA03
- ATC class
- Primidone
- Defined daily dose
- 1.25 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680178850145100 StkCHF 43.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
424 interactions on record for primidone.
Graded by severity as the source publishes them — 129 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Primidone · interactions on record
424 records
- 129 severe
- 199 moderate
- 8 minor
- 53 info
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- EliglustatA16AX10severe
35 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Primidone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEnodama 250mg tabletsDesitin Pharma Ltd
- United StatesMysolineBausch Health US, LLC
- NetherlandsMysoline tabletten 250 mgMedcor Pharmaceuticals B.V.
- NorwayLiskantinDesitin
- FinlandMysolineAstraZeneca Oy
- PolandMizodinZakłady Farmaceutyczne "UNIA" Spółdzielnia Pracy
- SwedenPrimidon Afortas 250 mg Tablett2care4 Generics ApS
- IrelandMysoline 250mg TabletsLaboratoires SERB
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Mysoline
- Belgium · Mysoline
- Czechia · Liskantin
- Germany · Liskantin, Liskantin Saft
- Denmark · Primidon Afortas, Primidon Orifarm
- Estonia · Liskantin
- Spain · Mysoline
- Finland · Primidon Afortas
- France · Mysoline
- United Kingdom (Northern Ireland) · Enodama, Mysoline
- Hungary · Sertan
- Ireland · Mysoline
- Italy · Mysoline
- Luxembourg · Mysoline
- Malta · Mysoline, Primidone Serb
- Netherlands · Mysoline
- Norway · Primidon Afortas
- Poland · Mizodin
- Portugal · Mysoline
- Sweden · Primidon Afortas
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8300353a-7fe5-4562-91a6-ea3e5d1d6c01 GET /v1/drugs/8300353a-7fe5-4562-91a6-ea3e5d1d6c01?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "primidonum 250 mg",
"valid_from": "1955-03-15",
"limitations": "[{\"description\":\"Patienten, die gegenüber allen anderen Standardtherapien refraktär sind. Bereits mit Mysoline eingestellte Patienten.<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2018-12-01\"}]",
"galenic_form": "Tabl 250 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1955-03-15",
"self_retention_pct": 10
}See everything about primidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.